Patent · US Active

Inhibiting transient receptor potential ion channel TRPA1

US9193729B2 · kind B2 · utility

5Cited by

3References

11Claims

0Family size

Assignee

Cubist Pharmaceuticals LLC · US

Inventors

Chester A. Metcalf, III · Needham, US
Yu Gui Gu · Acton, US
Spencer David Kimball · Plainsboro, US
Qingy Li · Waltham, US
Blaise S. Lippa · Newton, US
Dominic Ryan · Littleton, US
Xinyuan Wu · Newton, US
Dong Zou · Concord, US

Key dates

Filing date	Mar 15, 2013
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure describes a novel compounds and pharmaceutical compositions for inhibiting the TRPA1 ion channel and/or medical conditions related to TRPA1, such as pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.